Related references
Note: Only part of the references are listed.Association between indicators of cattle density and incidence of paediatric haemolytic-uraemic syndrome (HUS) in children under 15 years of age in France between 1996 and 2001: an ecological study
R. Haus-Cheymol et al.
EPIDEMIOLOGY AND INFECTION (2006)
Thrombotic thrombocytopenic purpura
JN George
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Predictors of fatality in postdiarrheal hemolytic uremic syndrome
RS Oakes et al.
PEDIATRICS (2006)
Escherichia coli O157:H7 infection in nursing homes:: Review of literature and report of recent outbreak
G Reiss et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome - III. An additional study of 57 consecutive patients, 2002-2005
MA Howard et al.
TRANSFUSION (2006)
The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency
DR Terrell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Childhood hemolytic uremic syndrome, United Kingdom and Ireland
RM Lynn et al.
EMERGING INFECTIOUS DISEASES (2005)
The Oklahoma Thrombotic Purpura-Hemolytic Uremic Thrombocytopenic Syndrome (TTP-HUS) Registry: A community perspective of patients with clinically diagnosed TTP-HUS
JN George et al.
SEMINARS IN HEMATOLOGY (2004)
Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children - A randomized controlled trial
H Trachtman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients
SK Vesely et al.
BLOOD (2003)
Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria:: A prospective study
A Gerber et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders:: a severely deficient activity is specific for thrombotic thrombocytopenic purpura
V Bianchi et al.
BLOOD (2002)
Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: Substantial underreporting and public health implications
KC Cummings et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome
WL Chandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Frequency, clinical features, and long-term outcomes
K Kojouri et al.
ANNALS OF INTERNAL MEDICINE (2001)
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
PM Mannucci et al.
BLOOD (2001)
The central Scotland Escherichia coli O157:H7 outbreak:: Risk factors for the hemolytic uremic syndrome and death among hospitalized patients
S Dundas et al.
CLINICAL INFECTIOUS DISEASES (2001)
Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features
EJ Elliott et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes
V Roy et al.
BONE MARROW TRANSPLANTATION (2001)
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
CS Wong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France
B Decludt et al.
EPIDEMIOLOGY AND INFECTION (2000)
Share Paper
